ClinicalTrials.Veeva

Menu

Cognate Patient Care Insight Scale (EIPSP)

H

Hôpital le Vinatier

Status

Withdrawn

Conditions

Schizophrenia

Treatments

Other: Assessment of the insight of schizophrenic patients by themselves, their relatives and caregivers

Study type

Interventional

Funder types

Other

Identifiers

NCT03071939
2016-A01716-45

Details and patient eligibility

About

Schizophrenia is a disease of young adults that affects 1% of the general population. According to numerous studies, it has been estimated that between 50% and 80% of patients with schizophrenia do not consider to have a mental disorder and are therefore not aware of their disorders. A poor degree of insight is associated with poor compliance, a higher number of re-hospitalizations, altered social and relational functioning, and a higher number of suicides and violent behaviors. This is why insight, which is an essential dimension of psychopathology, must be evaluated, as it depends to a large extent on the therapeutic alliance, adherence to treatment, likelihood of relapse and prognosis.

Full description

Evaluation (test, re-test) This new tool for assessing insight will allow for a discrepancy in assessment and a more refined assessment with a view to developing specific care for the patient and / or the relative with regard to the three dimensions Evaluated: disease, treatment and functional implications

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of schizophrenia
  • Age from 18 to 50 years old
  • Stabilized clinical condition (without therapeutic modification during the month prior to inclusion)
  • French language read, spoken and understood (patient and family member)
  • Having given his consent
  • Agreement of the guardian for persons under guardianship
  • Consent of the relative

Exclusion criteria

  • Refusal of patient or legal guardian
  • Refusal of the loved one
  • Patient and / or neurological disorder of neurological origin of vascular, infectious or neurodegenerative origin

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

patients with schizophrenia and their designated relatives
Other group
Description:
Evaluation of the patient's insight (an inclusion phase, followed by two evaluation phases on D0 and D7) by the patient, his / her close and two caregivers (inter-judicial fidelity)
Treatment:
Other: Assessment of the insight of schizophrenic patients by themselves, their relatives and caregivers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems